madman
Super Moderator
* newer generation of oral testosterone therapy is forcing the medical world to update outdated talking points
What if everything you thought you knew about testosterone therapy was wrong? For decades, we’ve been told oral testosterone is dangerous—hard on the liver, risky for the heart, and “not worth it.”
In this episode, I sit down with Shalin Shah, CEO of Marius Pharmaceuticals, to unpack what’s changed and why a newer generation of oral testosterone therapy is forcing the medical world to update outdated talking points. Source
We talk about KYZATREX® (testosterone undecanoate)—an FDA-approved oral testosterone option—and the science behind why modern oral testosterone is designed differently than older oral formulations that earned a bad reputation. Source One of the key concepts we discuss: newer oral testosterone undecanoate products are designed for intestinal/lymphatic absorption, which helps bypass first-pass liver metabolism—a major reason “oral testosterone = liver toxicity” became a blanket belief.
What if everything you thought you knew about testosterone therapy was wrong? For decades, we’ve been told oral testosterone is dangerous—hard on the liver, risky for the heart, and “not worth it.”
In this episode, I sit down with Shalin Shah, CEO of Marius Pharmaceuticals, to unpack what’s changed and why a newer generation of oral testosterone therapy is forcing the medical world to update outdated talking points. Source
We talk about KYZATREX® (testosterone undecanoate)—an FDA-approved oral testosterone option—and the science behind why modern oral testosterone is designed differently than older oral formulations that earned a bad reputation. Source One of the key concepts we discuss: newer oral testosterone undecanoate products are designed for intestinal/lymphatic absorption, which helps bypass first-pass liver metabolism—a major reason “oral testosterone = liver toxicity” became a blanket belief.